Home
About
FAQ
History (13)
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
Implementation of an Orthopedic Trauma Program to Safely Promote Resident Autonomy.
Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
Circumferential Adipofascial Graft for Prevention of Recurrence of Posttraumatic Radioulnar Synostosis.
Second-line treatment for metastatic pancreatic cancer.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Second-line treatment for metastatic pancreatic cancer.
Paluri RK, Kasi A, Young C, Posey JA. Second-line treatment for metastatic pancreatic cancer. Clin Adv Hematol Oncol. 2020 Feb; 18(2):106-115.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Deoxycytidine
Fluorouracil
Humans
Neoplasm Metastasis
Pancreatic Neoplasms
authors with profiles
Ravi K. Paluri MD, MPH